2023 Q2 Form 10-Q Financial Statement
#000149315223016481 Filed on May 12, 2023
Income Statement
Concept | 2023 Q2 | 2023 Q1 | 2022 Q1 |
---|---|---|---|
Revenue | $2.106M | $2.175M | $1.849M |
YoY Change | 12.69% | 17.64% | 40.0% |
Cost Of Revenue | $1.414M | $1.261M | $1.142M |
YoY Change | 10.08% | 10.38% | 29.96% |
Gross Profit | $691.5K | $914.5K | $706.8K |
YoY Change | 18.42% | 29.39% | 59.97% |
Gross Profit Margin | 32.84% | 42.04% | 38.23% |
Selling, General & Admin | $827.9K | $841.9K | $668.5K |
YoY Change | -33.65% | 25.94% | 11.21% |
% of Gross Profit | 119.71% | 92.06% | 94.58% |
Research & Development | |||
YoY Change | |||
% of Gross Profit | |||
Depreciation & Amortization | $16.73K | $14.45K | $15.89K |
YoY Change | -5.77% | -9.09% | -58.12% |
% of Gross Profit | 2.42% | 1.58% | 2.25% |
Operating Expenses | $827.9K | $841.9K | $668.5K |
YoY Change | -33.65% | 25.94% | 11.21% |
Operating Profit | -$136.3K | $72.61K | $38.31K |
YoY Change | -79.46% | 89.54% | -124.05% |
Interest Expense | $27.84K | $18.96K | -$53.47K |
YoY Change | 42.31% | -135.46% | -1507.11% |
% of Operating Profit | 26.11% | -139.57% | |
Other Income/Expense, Net | -$9.676K | -$181.00 | $1.500K |
YoY Change | -100.7% | -112.07% | -242.86% |
Pretax Income | -$146.0K | $72.43K | $12.51K |
YoY Change | -120.47% | 479.0% | -108.5% |
Income Tax | $5.784K | $8.160K | $13.57K |
% Of Pretax Income | 11.27% | 108.47% | |
Net Earnings | -$129.2K | -$49.41K | -$92.66K |
YoY Change | -142.03% | -46.67% | -36.93% |
Net Earnings / Revenue | -6.14% | -2.27% | -5.01% |
Basic Earnings Per Share | -$0.01 | $0.00 | $0.00 |
Diluted Earnings Per Share | -$0.01 | $0.00 | -$4.043K |
COMMON SHARES | |||
Basic Shares Outstanding | 22.94M shares | 22.94M shares | 22.92M shares |
Diluted Shares Outstanding | 22.94M shares | 22.94M shares |
Balance Sheet
Concept | 2023 Q2 | 2023 Q1 | 2022 Q1 |
---|---|---|---|
SHORT-TERM ASSETS | |||
Cash & Short-Term Investments | $841.5K | $863.0K | $592.6K |
YoY Change | 20.42% | 45.63% | 4.23% |
Cash & Equivalents | $836.8K | $863.0K | $490.7K |
Short-Term Investments | $4.680K | $102.0K | |
Other Short-Term Assets | $74.40K | $96.33K | $48.72K |
YoY Change | 16.91% | 97.72% | -66.2% |
Inventory | |||
Prepaid Expenses | $74.40K | $96.33K | |
Receivables | $646.6K | $725.6K | $736.9K |
Other Receivables | $58.16K | $87.02K | $159.5K |
Total Short-Term Assets | $1.621M | $1.772M | $1.538M |
YoY Change | -42.54% | 15.23% | 14.89% |
LONG-TERM ASSETS | |||
Property, Plant & Equipment | $154.3K | $132.4K | $854.1K |
YoY Change | 3.34% | -84.49% | 5.61% |
Goodwill | $1.426M | $1.426M | |
YoY Change | 0.0% | ||
Intangibles | |||
YoY Change | |||
Long-Term Investments | $341.2K | $334.6K | $386.0K |
YoY Change | -14.27% | -13.31% | -18.79% |
Other Assets | $3.263M | $3.328M | $396.7K |
YoY Change | 2.72% | 738.92% | 3.97% |
Total Long-Term Assets | $3.418M | $3.460M | $3.299M |
YoY Change | 2.75% | 4.88% | -3.94% |
TOTAL ASSETS | |||
Total Short-Term Assets | $1.621M | $1.772M | $1.538M |
Total Long-Term Assets | $3.418M | $3.460M | $3.299M |
Total Assets | $5.038M | $5.232M | $4.837M |
YoY Change | -18.03% | 8.17% | 1.34% |
SHORT-TERM LIABILITIES | |||
YoY Change | |||
Accounts Payable | $34.81K | $27.31K | $31.53K |
YoY Change | -7.31% | -13.4% | -34.95% |
Accrued Expenses | $553.9K | $541.1K | $494.7K |
YoY Change | -46.45% | 9.38% | 1.18% |
Deferred Revenue | |||
YoY Change | |||
Short-Term Debt | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Long-Term Debt Due | $30.47K | $30.27K | $206.2K |
YoY Change | 3.27% | -85.32% | 52.49% |
Total Short-Term Liabilities | $1.007M | $901.8K | $962.4K |
YoY Change | -36.64% | -6.29% | 36.08% |
LONG-TERM LIABILITIES | |||
Long-Term Debt | $39.11K | $46.81K | $648.0K |
YoY Change | -44.3% | -92.78% | -13.01% |
Other Long-Term Liabilities | $1.440M | $1.451M | $1.135M |
YoY Change | 26.22% | 27.88% | -0.35% |
Total Long-Term Liabilities | $2.393M | $2.540M | $1.783M |
YoY Change | 34.05% | 42.49% | -5.36% |
TOTAL LIABILITIES | |||
Total Short-Term Liabilities | $1.007M | $901.8K | $962.4K |
Total Long-Term Liabilities | $2.393M | $2.540M | $1.783M |
Total Liabilities | $3.400M | $3.442M | $2.715M |
YoY Change | 0.76% | 26.75% | 10.96% |
SHAREHOLDERS EQUITY | |||
Retained Earnings | -$11.52M | -$11.39M | |
YoY Change | 8.11% | ||
Common Stock | $2.294K | $2.294K | |
YoY Change | 0.0% | ||
Preferred Stock | |||
YoY Change | |||
Treasury Stock (at cost) | |||
YoY Change | |||
Treasury Stock Shares | |||
Shareholders Equity | $1.638M | $1.790M | $2.092M |
YoY Change | |||
Total Liabilities & Shareholders Equity | $5.038M | $5.232M | $4.837M |
YoY Change | -18.03% | 8.17% | 1.34% |
Cashflow Statement
Concept | 2023 Q2 | 2023 Q1 | 2022 Q1 |
---|---|---|---|
OPERATING ACTIVITIES | |||
Net Income | -$129.2K | -$49.41K | -$92.66K |
YoY Change | -142.03% | -46.67% | -36.93% |
Depreciation, Depletion And Amortization | $16.73K | $14.45K | $15.89K |
YoY Change | -5.77% | -9.09% | -58.12% |
Cash From Operating Activities | $83.33K | $71.61K | $101.6K |
YoY Change | -27.97% | -29.48% | -161.18% |
INVESTING ACTIVITIES | |||
Capital Expenditures | $38.59K | -$5.420K | |
YoY Change | -31.04% | ||
Acquisitions | |||
YoY Change | |||
Other Investing Activities | -$4.600K | $107.3K | -$4.180K |
YoY Change | -47.9% | -2666.99% | -88.95% |
Cash From Investing Activities | -$43.19K | $107.3K | -$9.600K |
YoY Change | 389.13% | -1217.71% | -78.99% |
FINANCING ACTIVITIES | |||
Cash Dividend Paid | |||
YoY Change | |||
Common Stock Issuance & Retirement, Net | |||
YoY Change | |||
Debt Paid & Issued, Net | |||
YoY Change | |||
Cash From Financing Activities | -66.36K | -$105.8K | -55.24K |
YoY Change | 50946.15% | 91.61% | -136.89% |
NET CHANGE | |||
Cash From Operating Activities | 83.33K | $71.61K | 101.6K |
Cash From Investing Activities | -43.19K | $107.3K | -9.600K |
Cash From Financing Activities | -66.36K | -$105.8K | -55.24K |
Net Change In Cash | -26.22K | $73.06K | 36.71K |
YoY Change | -124.57% | 99.02% | -159.28% |
FREE CASH FLOW | |||
Cash From Operating Activities | $83.33K | $71.61K | $101.6K |
Capital Expenditures | $38.59K | -$5.420K | |
Free Cash Flow | $44.74K | $71.61K | $107.0K |
YoY Change | -61.33% | -33.06% | -167.65% |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2023Q1 | dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001599117 | |
CY2023Q1 | dei |
Amendment Flag
AmendmentFlag
|
false | |
CY2023Q1 | dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | |
CY2023Q1 | dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
Q1 | |
CY2023Q1 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
usd | |
CY2022Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
usd | |
CY2023Q1 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
usd | |
CY2022Q4 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
usd | |
CY2023Q1 | us-gaap |
Gain Loss On Investments
GainLossOnInvestments
|
usd | |
CY2023Q1 | us-gaap |
Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
|
usd | |
CY2023Q1 | us-gaap |
Gain Loss On Condemnation
GainLossOnCondemnation
|
usd | |
CY2023Q1 | MNTR |
Increase In Accrued Investment Interest Income
IncreaseInAccruedInvestmentInterestIncome
|
usd | |
CY2023Q1 | us-gaap |
Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
|
usd | |
CY2023Q1 | us-gaap |
Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
|
usd | |
CY2023Q1 | us-gaap |
Increase Decrease In Finance Receivables
IncreaseDecreaseInFinanceReceivables
|
usd | |
CY2023Q1 | us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
usd | |
CY2023Q1 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
usd | |
CY2022Q1 | MNTR |
Payments To Proceeds From Investment Securities
PaymentsToProceedsFromInvestmentSecurities
|
usd | |
CY2023Q1 | MNTR |
Down Payment On Right Of Use Assets
DownPaymentOnRightOfUseAssets
|
usd | |
CY2023Q1 | MNTR |
Proceeds From Warrants Converted To Common Stock
ProceedsFromWarrantsConvertedToCommonStock
|
usd | |
CY2023Q1 | us-gaap |
Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
|
usd | |
CY2023Q1 | us-gaap |
Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
|
usd | |
CY2022Q1 | us-gaap |
Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
|
usd | |
CY2023Q1 | MNTR |
Property And Equipment Acquired Via Longterm Debt
PropertyAndEquipmentAcquiredViaLongtermDebt
|
usd | |
CY2023Q1 | MNTR |
Investment In Account Receivable Current
InvestmentInAccountReceivableCurrent
|
usd | |
CY2022Q4 | MNTR |
Investment In Account Receivable Current
InvestmentInAccountReceivableCurrent
|
usd | |
CY2023Q1 | MNTR |
Employee Retention Tax Credits
EmployeeRetentionTaxCredits
|
usd | |
CY2022Q4 | MNTR |
Employee Retention Tax Credits
EmployeeRetentionTaxCredits
|
usd | |
CY2023Q1 | MNTR |
Employee Retention Tax Credits As Refund
EmployeeRetentionTaxCreditsAsRefund
|
usd | |
CY2022Q1 | MNTR |
Employee Retention Tax Credits As Refund
EmployeeRetentionTaxCreditsAsRefund
|
usd | |
CY2023Q1 | MNTR |
Operating Lease Cost Included In Cost Of Goods
OperatingLeaseCostIncludedInCostOfGoods
|
usd | |
CY2023Q1 | us-gaap |
Short Term Lease Cost
ShortTermLeaseCost
|
usd | |
CY2022Q1 | us-gaap |
Short Term Lease Cost
ShortTermLeaseCost
|
usd | |
CY2023Q1 | MNTR |
Property Additions
PropertyAdditions
|
usd | |
CY2023Q1 | us-gaap |
Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
|
usd | |
CY2023Q1 | us-gaap |
Gain Loss On Sale Of Property
GainLossOnSaleOfProperty
|
usd | |
CY2023Q1 | dei |
Document Type
DocumentType
|
10-Q | |
CY2023Q1 | dei |
Document Quarterly Report
DocumentQuarterlyReport
|
true | |
CY2023Q1 | dei |
Document Period End Date
DocumentPeriodEndDate
|
2023-03-31 | |
CY2023Q1 | dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2023 | |
CY2023Q1 | dei |
Document Transition Report
DocumentTransitionReport
|
false | |
CY2023Q1 | dei |
Entity File Number
EntityFileNumber
|
000-55323 | |
CY2023Q1 | dei |
Entity Registrant Name
EntityRegistrantName
|
Mentor Capital, Inc. | |
CY2023Q1 | dei |
Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
|
DE | |
CY2023Q1 | dei |
Entity Tax Identification Number
EntityTaxIdentificationNumber
|
77-0395098 | |
CY2023Q1 | dei |
Entity Address Address Line1
EntityAddressAddressLine1
|
5964 Campus Court | |
CY2023Q1 | dei |
Entity Address City Or Town
EntityAddressCityOrTown
|
Plano | |
CY2023Q1 | dei |
Entity Address State Or Province
EntityAddressStateOrProvince
|
TX | |
CY2023Q1 | dei |
Entity Address Postal Zip Code
EntityAddressPostalZipCode
|
75093 | |
CY2023Q1 | dei |
City Area Code
CityAreaCode
|
(760) | |
CY2023Q1 | dei |
Local Phone Number
LocalPhoneNumber
|
788-4700 | |
CY2023Q1 | dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | |
CY2023Q1 | dei |
Entity Interactive Data Current
EntityInteractiveDataCurrent
|
Yes | |
CY2023Q1 | dei |
Entity Filer Category
EntityFilerCategory
|
Non-accelerated Filer | |
CY2023Q1 | dei |
Entity Small Business
EntitySmallBusiness
|
true | |
CY2023Q1 | dei |
Entity Emerging Growth Company
EntityEmergingGrowthCompany
|
true | |
CY2023Q1 | dei |
Entity Ex Transition Period
EntityExTransitionPeriod
|
false | |
CY2023Q1 | dei |
Entity Shell Company
EntityShellCompany
|
false | |
CY2023Q2 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
22941357 | shares |
CY2023Q1 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
862992 | usd |
CY2022Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
789930 | usd |
CY2023Q1 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
725570 | usd |
CY2022Q4 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
633778 | usd |
CY2023Q1 | us-gaap |
Other Receivables Net Current
OtherReceivablesNetCurrent
|
87021 | usd |
CY2022Q4 | us-gaap |
Other Receivables Net Current
OtherReceivablesNetCurrent
|
230322 | usd |
CY2023Q1 | us-gaap |
Prepaid Expense Current
PrepaidExpenseCurrent
|
96327 | usd |
CY2022Q4 | us-gaap |
Prepaid Expense Current
PrepaidExpenseCurrent
|
66000 | usd |
CY2023Q1 | us-gaap |
Assets Current
AssetsCurrent
|
1771910 | usd |
CY2022Q4 | us-gaap |
Assets Current
AssetsCurrent
|
1720030 | usd |
CY2023Q1 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
355725 | usd |
CY2022Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
355725 | usd |
CY2023Q1 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
223293 | usd |
CY2022Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
208847 | usd |
CY2023Q1 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
132432 | usd |
CY2022Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
146878 | usd |
CY2023Q1 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
354964 | usd |
CY2022Q4 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
370164 | usd |
CY2023Q1 | us-gaap |
Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
|
1212026 | usd |
CY2022Q4 | us-gaap |
Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
|
895323 | usd |
CY2023Q1 | us-gaap |
Accounts Receivable Net Noncurrent
AccountsReceivableNetNoncurrent
|
204573 | usd |
CY2022Q4 | us-gaap |
Accounts Receivable Net Noncurrent
AccountsReceivableNetNoncurrent
|
315309 | usd |
CY2023Q1 | us-gaap |
Deposit Assets
DepositAssets
|
25575 | usd |
CY2022Q4 | us-gaap |
Deposit Assets
DepositAssets
|
25575 | usd |
CY2023Q1 | us-gaap |
Long Term Investments
LongTermInvestments
|
104431 | usd |
CY2022Q4 | us-gaap |
Long Term Investments
LongTermInvestments
|
94431 | usd |
CY2023Q1 | us-gaap |
Goodwill
Goodwill
|
1426182 | usd |
CY2022Q4 | us-gaap |
Goodwill
Goodwill
|
1426182 | usd |
CY2023Q1 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
3327751 | usd |
CY2022Q4 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
3126984 | usd |
CY2023Q1 | us-gaap |
Assets
Assets
|
5232093 | usd |
CY2022Q4 | us-gaap |
Assets
Assets
|
4993892 | usd |
CY2023Q1 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
27305 | usd |
CY2022Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
32092 | usd |
CY2023Q1 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
541131 | usd |
CY2022Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
658743 | usd |
CY2023Q1 | MNTR |
Economic Injury Disaster Loan Current Portion
EconomicInjuryDisasterLoanCurrentPortion
|
12895 | usd |
CY2022Q4 | MNTR |
Economic Injury Disaster Loan Current Portion
EconomicInjuryDisasterLoanCurrentPortion
|
3191 | usd |
CY2023Q1 | us-gaap |
Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
|
225738 | usd |
CY2022Q4 | us-gaap |
Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
|
232058 | usd |
CY2023Q1 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
64484 | usd |
CY2022Q4 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
62861 | usd |
CY2023Q1 | us-gaap |
Long Term Debt Current
LongTermDebtCurrent
|
30266 | usd |
CY2022Q4 | us-gaap |
Long Term Debt Current
LongTermDebtCurrent
|
29011 | usd |
CY2023Q1 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
901819 | usd |
CY2022Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
1017956 | usd |
CY2023Q1 | us-gaap |
Defined Benefit Pension Plan Liabilities Noncurrent
DefinedBenefitPensionPlanLiabilitiesNoncurrent
|
1160446 | usd |
CY2022Q4 | us-gaap |
Defined Benefit Pension Plan Liabilities Noncurrent
DefinedBenefitPensionPlanLiabilitiesNoncurrent
|
1153948 | usd |
CY2023Q1 | MNTR |
Economic Injury Disaster Loan
EconomicInjuryDisasterLoan
|
147170 | usd |
CY2022Q4 | MNTR |
Economic Injury Disaster Loan
EconomicInjuryDisasterLoan
|
157869 | usd |
CY2023Q1 | us-gaap |
Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
|
894995 | usd |
CY2022Q4 | us-gaap |
Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
|
575852 | usd |
CY2023Q1 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
290480 | usd |
CY2022Q4 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
307303 | usd |
CY2023Q1 | us-gaap |
Long Term Debt Noncurrent
LongTermDebtNoncurrent
|
46811 | usd |
CY2022Q4 | us-gaap |
Long Term Debt Noncurrent
LongTermDebtNoncurrent
|
54865 | usd |
CY2023Q1 | us-gaap |
Liabilities Noncurrent
LiabilitiesNoncurrent
|
2539902 | usd |
CY2022Q4 | us-gaap |
Liabilities Noncurrent
LiabilitiesNoncurrent
|
2249837 | usd |
CY2023Q1 | us-gaap |
Liabilities
Liabilities
|
3441721 | usd |
CY2022Q4 | us-gaap |
Liabilities
Liabilities
|
3267793 | usd |
CY2023Q1 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.0001 | |
CY2022Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.0001 | |
CY2023Q1 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
5000000 | shares |
CY2022Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
5000000 | shares |
CY2023Q1 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
11 | shares |
CY2023Q1 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
11 | shares |
CY2022Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
11 | shares |
CY2022Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
11 | shares |
CY2023Q1 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
CY2022Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
CY2023Q1 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
75000000 | shares |
CY2022Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
75000000 | shares |
CY2023Q1 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
22941357 | shares |
CY2023Q1 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
22941357 | shares |
CY2022Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
22941357 | shares |
CY2022Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
22941357 | shares |
CY2023Q1 | us-gaap |
Common Stock Value
CommonStockValue
|
2294 | usd |
CY2022Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
2294 | usd |
CY2023Q1 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
13085993 | usd |
CY2022Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
13085993 | usd |
CY2023Q1 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-11394877 | usd |
CY2022Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-11345465 | usd |
CY2023Q1 | MNTR |
Noncontrolling Interest
NoncontrollingInterest
|
96962 | usd |
CY2022Q4 | MNTR |
Noncontrolling Interest
NoncontrollingInterest
|
-16723 | usd |
CY2023Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
1790372 | usd |
CY2022Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
1726099 | usd |
CY2023Q1 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
5232093 | usd |
CY2022Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
4993892 | usd |
CY2023Q1 | us-gaap |
Revenues
Revenues
|
2175135 | usd |
CY2022Q1 | us-gaap |
Revenues
Revenues
|
1848898 | usd |
CY2023Q1 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
1260601 | usd |
CY2022Q1 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
1149015 | usd |
CY2023Q1 | us-gaap |
Gross Profit
GrossProfit
|
914534 | usd |
CY2022Q1 | us-gaap |
Gross Profit
GrossProfit
|
699883 | usd |
CY2023Q1 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
841920 | usd |
CY2022Q1 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
668507 | usd |
CY2023Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
72614 | usd |
CY2022Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
31376 | usd |
CY2022Q1 | us-gaap |
Gain Loss On Investments
GainLossOnInvestments
|
-42680 | usd |
CY2023Q1 | us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
6660 | usd |
CY2022Q1 | us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
14353 | usd |
CY2023Q1 | us-gaap |
Interest Expense
InterestExpense
|
18959 | usd |
CY2022Q1 | us-gaap |
Interest Expense
InterestExpense
|
18207 | usd |
CY2022Q1 | us-gaap |
Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
|
26168 | usd |
CY2023Q1 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
12118 | usd |
CY2022Q1 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
1500 | usd |
CY2023Q1 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-181 | usd |
CY2022Q1 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-18866 | usd |
CY2023Q1 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
72433 | usd |
CY2022Q1 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
12510 | usd |
CY2023Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
8160 | usd |
CY2022Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
13570 | usd |
CY2023Q1 | us-gaap |
Profit Loss
ProfitLoss
|
64273 | usd |
CY2022Q1 | us-gaap |
Profit Loss
ProfitLoss
|
-1060 | usd |
CY2023Q1 | us-gaap |
Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
|
113685 | usd |
CY2022Q1 | us-gaap |
Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
|
91599 | usd |
CY2023Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-49412 | usd |
CY2022Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-92659 | usd |
CY2023Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.002 | |
CY2022Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.004 | |
CY2023Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
22941357 | shares |
CY2022Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
22941357 | shares |
CY2021Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
2078677 | usd |
CY2022Q1 | us-gaap |
Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
|
14346 | usd |
CY2022Q1 | us-gaap |
Profit Loss
ProfitLoss
|
-1060 | usd |
CY2022Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
2091963 | usd |
CY2022Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
1726099 | usd |
CY2023Q1 | us-gaap |
Profit Loss
ProfitLoss
|
64273 | usd |
CY2023Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
1790372 | usd |
CY2023Q1 | us-gaap |
Profit Loss
ProfitLoss
|
64273 | usd |
CY2022Q1 | us-gaap |
Profit Loss
ProfitLoss
|
-1060 | usd |
CY2023Q1 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
14446 | usd |
CY2022Q1 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
15890 | usd |
CY2023Q1 | us-gaap |
Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
|
95169 | usd |
CY2022Q1 | us-gaap |
Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
|
36656 | usd |
CY2022Q1 | us-gaap |
Gain Loss On Condemnation
GainLossOnCondemnation
|
26168 | usd |
CY2023Q1 | MNTR |
Amortization Of Discount On Investment In Account Receivable
AmortizationOfDiscountOnInvestmentInAccountReceivable
|
-6564 | usd |
CY2022Q1 | MNTR |
Amortization Of Discount On Investment In Account Receivable
AmortizationOfDiscountOnInvestmentInAccountReceivable
|
-13470 | usd |
CY2022Q1 | MNTR |
Increase In Accrued Investment Interest Income
IncreaseInAccruedInvestmentInterestIncome
|
-878 | usd |
CY2022Q1 | us-gaap |
Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
|
-250 | usd |
CY2022Q1 | us-gaap |
Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
|
-42430 | usd |
CY2022Q1 | us-gaap |
Increase Decrease In Finance Receivables
IncreaseDecreaseInFinanceReceivables
|
-19662 | usd |
CY2023Q1 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
91792 | usd |
CY2022Q1 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
30447 | usd |
CY2023Q1 | us-gaap |
Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
|
-143301 | usd |
CY2022Q1 | us-gaap |
Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
|
-14153 | usd |
CY2023Q1 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
32322 | usd |
CY2022Q1 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
8268 | usd |
CY2023Q1 | us-gaap |
Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
|
-1995 | usd |
CY2022Q1 | us-gaap |
Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
|
-1150 | usd |
CY2023Q1 | us-gaap |
Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
|
-4787 | usd |
CY2022Q1 | us-gaap |
Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
|
-9746 | usd |
CY2023Q1 | us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
-118607 | usd |
CY2022Q1 | us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
55830 | usd |
CY2022Q1 | us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
-1136 | usd |
CY2023Q1 | us-gaap |
Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
|
6498 | usd |
CY2022Q1 | us-gaap |
Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
|
6700 | usd |
CY2023Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
71610 | usd |
CY2022Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
101548 | usd |
CY2022Q1 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
5422 | usd |
CY2023Q1 | MNTR |
Payments To Proceeds From Investment Securities
PaymentsToProceedsFromInvestmentSecurities
|
10000 | usd |
CY2022Q1 | MNTR |
Down Payment On Right Of Use Assets
DownPaymentOnRightOfUseAssets
|
4280 | usd |
CY2023Q1 | us-gaap |
Proceeds From Sale And Maturity Of Other Investments
ProceedsFromSaleAndMaturityOfOtherInvestments
|
117300 | usd |
CY2022Q1 | us-gaap |
Proceeds From Sale And Maturity Of Other Investments
ProceedsFromSaleAndMaturityOfOtherInvestments
|
100 | usd |
CY2023Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
107300 | usd |
CY2022Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-9602 | usd |
CY2022Q1 | MNTR |
Proceeds From Warrants Converted To Common Stock
ProceedsFromWarrantsConvertedToCommonStock
|
14346 | usd |
CY2022Q1 | us-gaap |
Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
|
21950 | usd |
CY2023Q1 | MNTR |
Payments On Longterm Debt
PaymentsOnLongtermDebt
|
6799 | usd |
CY2022Q1 | MNTR |
Payments On Longterm Debt
PaymentsOnLongtermDebt
|
5294 | usd |
CY2023Q1 | us-gaap |
Finance Lease Principal Payments
FinanceLeasePrincipalPayments
|
99049 | usd |
CY2022Q1 | us-gaap |
Finance Lease Principal Payments
FinanceLeasePrincipalPayments
|
42339 | usd |
CY2023Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
-105848 | usd |
CY2022Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
-55237 | usd |
CY2023Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
|
73062 | usd |
CY2022Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
|
36709 | usd |
CY2022Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
789930 | usd |
CY2021Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
453939 | usd |
CY2023Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
862992 | usd |
CY2022Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
490648 | usd |
CY2023Q1 | us-gaap |
Interest Paid Net
InterestPaidNet
|
12737 | usd |
CY2022Q1 | us-gaap |
Interest Paid Net
InterestPaidNet
|
11553 | usd |
CY2023Q1 | us-gaap |
Income Taxes Paid Net
IncomeTaxesPaidNet
|
3568 | usd |
CY2022Q1 | us-gaap |
Income Taxes Paid Net
IncomeTaxesPaidNet
|
1730 | usd |
CY2023Q1 | us-gaap |
Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
|
411872 | usd |
CY2022Q1 | us-gaap |
Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
|
46760 | usd |
CY2022Q1 | MNTR |
Property And Equipment Acquired Via Longterm Debt
PropertyAndEquipmentAcquiredViaLongtermDebt
|
22480 | usd |
CY2023Q1 | us-gaap |
Nature Of Operations
NatureOfOperations
|
<p id="xdx_800_eus-gaap--NatureOfOperations_zO4cwJtOYx9k" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="catty_007"/>Note 1 - <span id="xdx_82B_z1obumXdjuGl">Nature of operations</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Corporate Structure Overview</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 35.1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mentor Capital, Inc. (“Mentor” or “the Company”), reincorporated under the laws of the State of <span id="xdx_903_edei--EntityIncorporationStateCountryCode_c20230101__20230331_zScLC7eoovF2" title="Entity incorporation, state or country code">Delaware</span> in September 2015.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.3pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The entity was originally founded as an investment partnership in Silicon Valley, California, by the current CEO in 1985 and subsequently incorporated under the laws of the State of California on <span id="xdx_908_edei--EntityIncorporationDateOfIncorporation_dd_c20230101__20230331_zXGW6Kl5eWM2" title="Entity incorporation, date of incorporation">July 29, 1994</span>. On September 12, 1996, the Company’s offering statement was qualified pursuant to Regulation A of the Securities Act, and the Company began to trade its shares publicly. On August 21, 1998, the Company filed for voluntary reorganization, and on January 11, 2000, the Company emerged from Chapter 11 reorganization. The Company relocated to San Diego, California, and contracted to provide financial assistance and investment in small businesses. On May 22, 2015, a corporation named Mentor Capital, Inc. (“Mentor Delaware”) was incorporated under the laws of the State of Delaware. A shareholder-approved merger between Mentor and Mentor Delaware was approved by the California and Delaware Secretaries of State and became effective September 24, 2015, thereby establishing Mentor as a Delaware corporation. In September 2020, Mentor relocated its corporate office from San Diego, California, to Plano, Texas.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.3pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s common stock trades publicly under the trading symbol OTCQB: MNTR.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.3pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s broad target industry focus includes energy, staffing, facilities operations, and management services with the goal of ensuring increased market opportunities.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.3pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mentor has a <span id="xdx_901_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20230331__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--WasteConsolidatorsIncMember_zHzssRexj1lg" title="Equity method investment, ownership percentage">51</span>% interest in Waste Consolidators, Inc. (“WCI”). WCI was incorporated in Colorado in 1999 and operates in Arizona and Texas. It is a long-standing investment of the Company since 2003.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mentor’s <span id="xdx_90E_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20230331__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--MentorIPLLCMember_zuQlbd3540Xa" title="Equity method investment, ownership percentage">100</span>% owned subsidiaries, Mentor IP, LLC (“MCIP”), Mentor Partner I, LLC, (“Partner I”), Mentor Partner II, LLC (“Partner II”), and TWG, LLC (“TWG”), are headquartered in Plano, Texas.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.3pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">MCIP holds intellectual property and licensing rights related to one United States and one Canadian patent associated with THC and CBD vape pens. Patent application and national phase maintenance fees were expensed when paid rather than capitalized and therefore, no capitalized assets related to MCIP are recognized on the consolidated financial statements at March 31, 2023 and December 31, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On August 27, 2021, the Company and Mentor Partner I entered into a Settlement Agreement and Mutual Release with the G Farma Entities and guarantors (“G Farma Settlors”) to resolve and settle all outstanding claims on an unpaid finance lease receivable and notes receivable of balances of $<span id="xdx_90E_eus-gaap--FinanceLeaseLiabilityNoncurrent_iI_c20210827__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--GFarmaSettlorsMember__us-gaap--TypeOfArrangementAxis__custom--SettlementAgreementAndMutualReleaseMember_zs9pvVeyID2h" title="Finance lease receivable">803,399</span> and $<span id="xdx_90C_eus-gaap--NotesReceivableGross_iI_c20210827__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--GFarmaSettlorsMember__us-gaap--TypeOfArrangementAxis__custom--SettlementAgreementAndMutualReleaseMember_zzHCrTPEEYEi" title="Notes receivable">1,045,051</span>, respectively, plus accrued interest (“Settlement Agreement”). On October 12, 2021, the parties filed a Stipulation for Dismissal and Continued Jurisdiction with the Superior Court of California in the County of Marin. The Court ordered that it retain jurisdiction over the parties under Section 664.6 of the California Code of Civil Procedure to enforce the Settlement Agreement until the performance in full of its terms is met.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In August 2022, September 2022, and October 2022, the G Farma Settlors failed to make monthly payments, and failed to cure each default within 10 days’ notice from Company pursuant to the Settlement Agreement. As a result, $<span id="xdx_907_eus-gaap--LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseOpeningBalanceAdjustments_iI_c20220831__us-gaap--TypeOfArrangementAxis__custom--SettlementAgreementAndMutualReleaseMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--GFarmaSettlorsMember_zdE0ZAgcn7g3" title="Liability for unpaid claims"><span id="xdx_904_eus-gaap--LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseOpeningBalanceAdjustments_iI_c20220930__us-gaap--TypeOfArrangementAxis__custom--SettlementAgreementAndMutualReleaseMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--GFarmaSettlorsMember_zpyb5sl0kN12" title="Liability for unpaid claims"><span id="xdx_903_eus-gaap--LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseOpeningBalanceAdjustments_iI_c20221031__us-gaap--TypeOfArrangementAxis__custom--SettlementAgreementAndMutualReleaseMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--GFarmaSettlorsMember_z0JSYwTO88oa" title="Liability for unpaid claims">2,000,000</span></span></span> should be added to the amount payable by the G Farma Settlors in accordance with the terms of the Settlement Agreement. The Company is requesting that the stipulated judgment be entered against the G Farma Settlors for (1) the remaining amount of the $<span id="xdx_904_eus-gaap--LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_iI_c20220831__us-gaap--TypeOfArrangementAxis__custom--SettlementAgreementAndMutualReleaseMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--GFarmaSettlorsMember_zuSK7XVDPbue" title="Liability for unpaid claims and claims adjustment expense, net"><span id="xdx_90D_eus-gaap--LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_iI_c20220930__us-gaap--TypeOfArrangementAxis__custom--SettlementAgreementAndMutualReleaseMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--GFarmaSettlorsMember_zVDjGaEf1rvi" title="Liability for unpaid claims and claims adjustment expense, net"><span id="xdx_909_eus-gaap--LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_iI_c20221031__us-gaap--TypeOfArrangementAxis__custom--SettlementAgreementAndMutualReleaseMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--GFarmaSettlorsMember_zz6vzbmG5zYb" title="Liability for unpaid claims and claims adjustment expense, net">500,000</span></span></span> settlement amount which has not yet been paid by the G Farma Settlors plus $<span id="xdx_902_ecustom--LiabilityForAccruedUnpaidInterest_iI_c20220831__us-gaap--TypeOfArrangementAxis__custom--SettlementAgreementAndMutualReleaseMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--GFarmaSettlorsMember_zTsLCOuSL4l3" title="Liability for accrued unpaid interest"><span id="xdx_902_ecustom--LiabilityForAccruedUnpaidInterest_iI_c20220930__us-gaap--TypeOfArrangementAxis__custom--SettlementAgreementAndMutualReleaseMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--GFarmaSettlorsMember_zwqgQfjuyUrl" title="Liability for accrued unpaid interest"><span id="xdx_904_ecustom--LiabilityForAccruedUnpaidInterest_iI_c20221031__us-gaap--TypeOfArrangementAxis__custom--SettlementAgreementAndMutualReleaseMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--GFarmaSettlorsMember_zxtLKTT62j32" title="Liability for accrued unpaid interest">2,000,000</span></span></span> and all accrued unpaid interest, (2) the Company’s incurred costs, and (3) attorneys’ fees paid by the Company to obtain the judgment.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has retained the reserve on collections of the unpaid lease receivable balance due to the long history of uncertain payments from G Farma. Payments from G Farma will be recognized in Other Income as they are received. Recovery payments of $<span id="xdx_90B_eus-gaap--OtherIncome_c20220101__20221231__dei--LegalEntityAxis__custom--GFarmaLabsLimitedMember_zGvE1EStDd2j" title="Other income">3,550</span> and $<span id="xdx_909_eus-gaap--OtherIncome_c20210101__20211231__dei--LegalEntityAxis__custom--GFarmaLabsLimitedMember_zOYxPd96jTSb" title="Other income">2,000</span> were included in other income in the consolidated financial statements for the year ended December 31, 2022 and 2021, respectively. No recovery payments have received since October 11, 2022. We will continue to pursue collection from the G Farma Settlors over time. See Notes 8 and 18.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 1 - Nature of operations (continued)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On September 27, 2022, Pueblo West Organics, LLC, a Colorado limited liability company (“Pueblo West”) exercised a lease prepayment option and purchased manufacturing equipment from Partner II for $<span id="xdx_905_eus-gaap--PaymentsToAcquireMachineryAndEquipment_pdp0_c20220926__20220927__dei--LegalEntityAxis__custom--PuebloWestOrganicsLLCMember_zFf6Atj6Tooa" title="Payments to acquire machinery and equipment">245,369</span>. On September 28, 2022 Partner II transferred full title to the equipment to Pueblo West. Originally, Mentor contributed $<span id="xdx_903_eus-gaap--LimitedPartnersContributedCapital_iI_pp0p0_c20180208__dei--LegalEntityAxis__custom--MentorPartnerIILLCMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ManufacturingFacilityMember_zVEbfBBDUnmd" title="Capital contribution">400,000</span> to Partner II to facilitate the purchase of manufacturing equipment to be leased from Partner II by Pueblo West under a Master Equipment Lease Agreement dated February 11, 2018, as amended. On March 12, 2019, Mentor agreed to use Partner II earnings of $<span id="xdx_907_eus-gaap--PaymentsToAcquireMachineryAndEquipment_pp0p0_c20190311__20190312__dei--LegalEntityAxis__custom--MentorPartnerIILLCMember_zJuMPPoOj4jl" title="Payments to acquire machinery and equipment">61,368</span> to facilitate the purchase of additional manufacturing equipment to Pueblo West under a Second Amendment to the lease. See Note 8.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On November 18, 2022, following the filing of a declaratory relief action, Mentor received $<span id="xdx_905_ecustom--ContractualInterestsInLegalRecoveriess_c20221117__20221118__us-gaap--TypeOfArrangementAxis__custom--SettlementAgreementMember_zMtYR1T4UMff" title="Contractual interests in legal recoveriess">459,990</span> from Electrum Partners, LLC (“Electrum”) pursuant to a certain November 14, 2022 Settlement Agreement and Mutual Release, following the Company’s October 21, 2022 lawsuit against Electrum and the escrow agent in the County of San Mateo. The Company applied $<span id="xdx_903_ecustom--ContractualInterestsInLegalRecoveries_iI_c20221118__us-gaap--TypeOfArrangementAxis__custom--RecoveryPurchaseAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ElectrumPartnersLLCMember_zJikR5vPiCwf" title="Contractual interests in legal recoveries">196,666</span> to a certain October 30, 2018, Recovery Purchase Agreement, and $<span id="xdx_901_ecustom--ContractualInterestsInLegalRecoveries_iI_c20221118__us-gaap--TypeOfArrangementAxis__custom--CapitalAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ElectrumPartnersLLCMember_z5iFZZZxaIb6" title="Contractual interests in legal recoveries">200,000</span> to an October 31, 2018 and January 28, 2019 Capital Agreement. The Company applied the remaining $<span id="xdx_90B_ecustom--ContractualInterestsInLegalRecoveries_iI_c20221118__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ElectrumPartnersLLCMember_zYgI7Fqxmrgk" title="Contractual interests in legal recoveries">63,324</span> to its $<span id="xdx_904_ecustom--ContractualInterestEquityInterest_iI_pp0p0_c20190128__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ElectrumPartnersLLCMember__us-gaap--TypeOfArrangementAxis__custom--SecondSecuredCapitalAgreementMember_zoU2tzErqyn2" title="Contractual interest equity interest">194,028</span> equity interest in Electrum; this resulted in a $<span id="xdx_906_eus-gaap--LossOnSaleOfInvestments_pp0p0_c20221117__20221118__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ElectrumPartnersLLCMember_zf991puUyr4i" title="Loss on investment">130,704</span> loss on the Company’s investment in Electrum. See Note 9.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On December 21, 2018, Mentor paid $<span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pp0p0_c20181201__20181221__dei--LegalEntityAxis__custom--NeuCourtIncMember_z2WiApBp9Bzj" title="Stock issued, value">10,000</span> to purchase <span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20181201__20181221__dei--LegalEntityAxis__custom--NeuCourtIncMember_zipWuJqoLuhf" title="Stock issued, shares">500,000</span> shares of NeuCourt, Inc. (“NeuCourt”) common stock, representing approximately<span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum_pid_dp_c20230101__20230331__dei--LegalEntityAxis__custom--NeuCourtIncMember_zoneLmOPv8He" title="Entity issued and outstanding common stock, percentage"> 6.13</span>% of NeuCourt’s issued and outstanding common stock at March 31, 2023.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> | |
CY2023Q1 | dei |
Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
|
DE | |
CY2023Q1 | dei |
Entity Incorporation Date Of Incorporation
EntityIncorporationDateOfIncorporation
|
1994-07-29 | |
CY2023Q1 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-11394877 | usd |
CY2022Q4 | us-gaap |
Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
|
53692 | usd |
CY2021 | us-gaap |
Impairment Of Investments
ImpairmentOfInvestments
|
116430 | usd |
CY2022Q1 | us-gaap |
Gain Loss On Investments
GainLossOnInvestments
|
41930 | usd |
CY2023Q1 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<p id="xdx_84D_eus-gaap--UseOfEstimates_zT3i6b3hjQe2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_86B_zJ1YUcgrFgY">Use of estimates</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 35.1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of our condensed consolidated financial statements in conformity with GAAP requires management to make estimates, assumptions, and judgments that affect the reported amounts of assets and liabilities, and the disclosure of contingent assets and liabilities at the date of our consolidated financial statements, and the reported amount of revenues and expenses during the reporting period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Note 2 - Summary of significant accounting policies (continued)</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Significant estimates relied upon in preparing these consolidated financial statements include revenue recognition, accounts and notes receivable reserves, expected future cash flows used to evaluate the recoverability of long-lived assets, estimated fair values of long-lived assets used to record impairment charges related to investments, goodwill, amortization periods, accrued expenses, and recoverability of the Company’s net deferred tax assets and any related valuation allowance.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.3pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although the Company regularly assesses these estimates, actual results could differ materially from these estimates. Changes in estimates are recorded in the period in which they become known. The Company bases its estimates on historical experience and various other assumptions that it believes to be reasonable under the circumstances. Actual results may differ from management’s estimates if past experience or other assumptions do not turn out to be substantially accurate.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> | |
CY2023Q1 | us-gaap |
Short Term Investments
ShortTermInvestments
|
0 | usd |
CY2022Q4 | us-gaap |
Short Term Investments
ShortTermInvestments
|
0 | usd |
CY2023Q1 | us-gaap |
Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
|
51959 | usd |
CY2021 | us-gaap |
Impairment Of Investments
ImpairmentOfInvestments
|
116430 | usd |
CY2022Q1 | us-gaap |
Gain Loss On Investments
GainLossOnInvestments
|
41930 | usd |
CY2023Q1 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
6700000 | shares |
CY2023Q1 | us-gaap |
Property Plant And Equipment Impairment
PropertyPlantAndEquipmentImpairment
|
<p id="xdx_84D_eus-gaap--PropertyPlantAndEquipmentImpairment_zBWtYQQLoBzl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_861_zG8xG3ZUqlUk">Property and equipment</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 35.1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property and equipment are recorded at cost less accumulated depreciation. Depreciation is computed on the declining balance method over the estimated useful lives of various classes of property. The estimated lives of the property and equipment are generally as follows: computer equipment, <span id="xdx_90C_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230331__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember__srt--RangeAxis__srt--MinimumMember_z59weZa35oS1">3</span> to <span id="xdx_903_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230331__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember__srt--RangeAxis__srt--MaximumMember_zZFEEW0AvaZi">5</span> years; furniture and equipment, <span id="xdx_90A_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230331__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zKM883Qzy7oh">7</span> years; and vehicles and trailers, <span id="xdx_90E_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230331__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--VehiclesMember__srt--RangeAxis__srt--MinimumMember_zkdosxCX3iof">4</span> to <span id="xdx_903_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230331__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--VehiclesMember__srt--RangeAxis__srt--MaximumMember_zAzIPj09Oda8" title="Estimated lives of property and equipment">5</span> years. Depreciation on vehicles used by WCI to service its customers is included in cost of goods sold in the consolidated income statements. All other depreciation is included in selling, general and administrative costs in the consolidated income statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expenditures for major renewals and improvements are capitalized, while minor replacements, maintenance, and repairs, which do not extend the asset lives, are charged to operations as incurred. Upon sale or disposition, the cost and related accumulated depreciation are removed from the accounts, and any gain or loss is included in operations. The Company continually monitors events and changes in circumstances that could indicate that the carrying balances of its property and equipment may not be recoverable in accordance with the provisions of ASC 360, <i>“Property, Plant, and Equipment.” </i>When such events or changes in circumstances are present, the Company assesses the recoverability of long-lived assets by determining whether the carrying value of such assets will be recovered through undiscounted expected future cash flows. If the total of the future cash flows is less than the carrying amount of those assets, the Company recognizes an impairment loss based on the excess of the carrying amount over the fair value of the assets.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company reviews intangible assets subject to amortization quarterly to determine if any adverse conditions exist or a change in circumstances has occurred that would indicate impairment or a change in the remaining useful life. Conditions that may indicate impairment include, but are not limited to, a significant adverse change in legal factors or business climate that could affect the value of an asset, a product recall, or an adverse action or assessment by a regulator. If an impairment indicator exists, we test the intangible asset for recoverability. For purposes of the recoverability test, we group our amortizable intangible assets with other assets and liabilities at the lowest level of identifiable cash flows if the intangible asset does not generate cash flows independent of other assets and liabilities. If the carrying value of the intangible asset (asset group) exceeds the undiscounted cash flows expected to result from the use and eventual disposition of the intangible asset (asset group), the Company will write the carrying value down to the fair value in the period identified.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> | |
CY2022 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
6700000 | shares |
CY2023Q1 | us-gaap |
Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
|
0 | shares |
CY2022 | us-gaap |
Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
|
0 | shares |
CY2021 | MNTR |
Impairment Of Investments1
ImpairmentOfInvestments1
|
-139148 | usd |
CY2021 | us-gaap |
Gain Loss On Investments
GainLossOnInvestments
|
22718 | usd |
CY2022 | us-gaap |
Gain Loss On Investments
GainLossOnInvestments
|
41930 | usd |
CY2021 | us-gaap |
Gain Loss On Investments
GainLossOnInvestments
|
22718 | usd |
CY2023Q1 | MNTR |
Purchase Obligation Due In Current Year
PurchaseObligationDueInCurrentYear
|
117000 | usd |
CY2023Q1 | us-gaap |
Purchase Obligation Due In Next Twelve Months
PurchaseObligationDueInNextTwelveMonths
|
117000 | usd |
CY2023Q1 | us-gaap |
Purchase Obligation Due In Second Year
PurchaseObligationDueInSecondYear
|
117000 | usd |
CY2023Q1 | us-gaap |
Purchase Obligation Due In Third Year
PurchaseObligationDueInThirdYear
|
117000 | usd |
CY2023Q1 | MNTR |
Investment In Account Receivable Face Value
InvestmentInAccountReceivableFaceValue
|
286300 | usd |
CY2022Q4 | MNTR |
Investment In Account Receivable Face Value
InvestmentInAccountReceivableFaceValue
|
403600 | usd |
CY2023Q1 | MNTR |
Investment In Account Receivable Unamortized Discount
InvestmentInAccountReceivableUnamortizedDiscount
|
81727 | usd |
CY2022Q4 | MNTR |
Investment In Account Receivable Unamortized Discount
InvestmentInAccountReceivableUnamortizedDiscount
|
88291 | usd |
CY2023Q1 | MNTR |
Investment In Account Receivable Net
InvestmentInAccountReceivableNet
|
204573 | usd |
CY2022Q4 | MNTR |
Investment In Account Receivable Net
InvestmentInAccountReceivableNet
|
315309 | usd |
CY2023Q1 | MNTR |
Investment In Account Receivable Noncurrent
InvestmentInAccountReceivableNoncurrent
|
204573 | usd |
CY2022Q4 | MNTR |
Investment In Account Receivable Noncurrent
InvestmentInAccountReceivableNoncurrent
|
315309 | usd |
CY2023Q1 | MNTR |
Purchase Obligation Due In Current Year
PurchaseObligationDueInCurrentYear
|
117000 | usd |
CY2023Q1 | MNTR |
Investment In Accounts Receivable Face Value
InvestmentInAccountsReceivableFaceValue
|
117000 | usd |
CY2023Q1 | MNTR |
Investment In Accounts Receivable Face Value
InvestmentInAccountsReceivableFaceValue
|
100 | usd |
CY2023Q1 | MNTR |
Investment In Accounts Receivable Face Value
InvestmentInAccountsReceivableFaceValue
|
100 | usd |
CY2023Q1 | MNTR |
Investment In Accounts Receivable Face Value
InvestmentInAccountsReceivableFaceValue
|
100 | usd |
CY2023Q1 | us-gaap |
Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
|
6456 | usd |
CY2022Q1 | us-gaap |
Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
|
13470 | usd |
CY2023Q1 | MNTR |
Sales Tax Receivable
SalesTaxReceivable
|
93942 | usd |
CY2022Q4 | MNTR |
Sales Tax Receivable
SalesTaxReceivable
|
237243 | usd |
CY2023Q1 | us-gaap |
Other Receivables Gross Current
OtherReceivablesGrossCurrent
|
6921 | usd |
CY2022Q4 | us-gaap |
Other Receivables Gross Current
OtherReceivablesGrossCurrent
|
6921 | usd |
CY2023Q1 | us-gaap |
Other Receivables Net Current
OtherReceivablesNetCurrent
|
87021 | usd |
CY2022Q4 | us-gaap |
Other Receivables Net Current
OtherReceivablesNetCurrent
|
230322 | usd |
CY2022 | MNTR |
Employee Retention Credits
EmployeeRetentionCredits
|
1350161 | usd |
CY2021Q4 | MNTR |
Employee Retention Tax Credits As Refund
EmployeeRetentionTaxCreditsAsRefund
|
33222 | usd |
CY2023Q1 | us-gaap |
Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
|
31335 | usd |
CY2022Q4 | us-gaap |
Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
|
31335 | usd |
CY2023Q1 | us-gaap |
Furniture And Fixtures Gross
FurnitureAndFixturesGross
|
27374 | usd |
CY2022Q4 | us-gaap |
Furniture And Fixtures Gross
FurnitureAndFixturesGross
|
27374 | usd |
CY2023Q1 | us-gaap |
Machinery And Equipment Gross
MachineryAndEquipmentGross
|
297016 | usd |
CY2022Q4 | us-gaap |
Machinery And Equipment Gross
MachineryAndEquipmentGross
|
297016 | usd |
CY2023Q1 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
355725 | usd |
CY2022Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
355725 | usd |
CY2023Q1 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
223293 | usd |
CY2022Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
208847 | usd |
CY2023Q1 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
132432 | usd |
CY2022Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
146878 | usd |
CY2023Q1 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
14446 | usd |
CY2022Q1 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
15890 | usd |
CY2022Q1 | MNTR |
Operating Lease Cost Included In Cost Of Goods
OperatingLeaseCostIncludedInCostOfGoods
|
7964 | usd |
CY2023Q1 | MNTR |
Operating Lease Cost Included In Operating Costs
OperatingLeaseCostIncludedInOperatingCosts
|
22179 | usd |
CY2022Q1 | MNTR |
Operating Lease Cost Included In Operating Costs
OperatingLeaseCostIncludedInOperatingCosts
|
7200 | usd |
CY2023Q1 | us-gaap |
Operating Lease Cost
OperatingLeaseCost
|
22179 | usd |
CY2022Q1 | us-gaap |
Operating Lease Cost
OperatingLeaseCost
|
15164 | usd |
CY2023Q1 | us-gaap |
Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
|
76768 | usd |
CY2022Q1 | us-gaap |
Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
|
47416 | usd |
CY2023Q1 | us-gaap |
Finance Lease Interest Expense
FinanceLeaseInterestExpense
|
14483 | usd |
CY2022Q1 | us-gaap |
Finance Lease Interest Expense
FinanceLeaseInterestExpense
|
6929 | usd |
CY2023Q1 | MNTR |
Financing Lease Cost
FinancingLeaseCost
|
91251 | usd |
CY2022Q1 | MNTR |
Financing Lease Cost
FinancingLeaseCost
|
54345 | usd |
CY2023Q1 | us-gaap |
Lease Cost
LeaseCost
|
113430 | usd |
CY2022Q1 | us-gaap |
Lease Cost
LeaseCost
|
69509 | usd |
CY2023Q1 | us-gaap |
Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
|
P4Y9M | |
CY2022Q4 | us-gaap |
Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
|
P4Y9M | |
CY2023Q1 | us-gaap |
Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
|
P3Y8M23D | |
CY2022Q4 | us-gaap |
Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
|
P4Y7M17D | |
CY2023Q1 | us-gaap |
Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
|
0.060 | pure |
CY2022Q4 | us-gaap |
Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
|
0.060 | pure |
CY2023Q1 | us-gaap |
Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
|
0.069 | pure |
CY2022Q4 | us-gaap |
Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
|
0.055 | pure |
CY2023Q1 | us-gaap |
Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
|
1268848 | usd |
CY2022Q4 | us-gaap |
Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
|
897849 | usd |
CY2023Q1 | us-gaap |
Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
|
148115 | usd |
CY2022Q4 | us-gaap |
Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
|
89939 | usd |
CY2023Q1 | us-gaap |
Finance Lease Liability
FinanceLeaseLiability
|
1120733 | usd |
CY2022Q4 | us-gaap |
Finance Lease Liability
FinanceLeaseLiability
|
807910 | usd |
CY2023Q1 | us-gaap |
Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
|
225738 | usd |
CY2022Q4 | us-gaap |
Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
|
232058 | usd |
CY2023Q1 | us-gaap |
Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
|
894995 | usd |
CY2022Q4 | us-gaap |
Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
|
575852 | usd |
CY2023Q1 | us-gaap |
Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
|
437219 | usd |
CY2022Q4 | us-gaap |
Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
|
428946 | usd |
CY2023Q1 | us-gaap |
Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
|
82255 | usd |
CY2022Q4 | us-gaap |
Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
|
58782 | usd |
CY2023Q1 | us-gaap |
Operating Lease Liability
OperatingLeaseLiability
|
354964 | usd |
CY2022Q4 | us-gaap |
Operating Lease Liability
OperatingLeaseLiability
|
370164 | usd |
CY2023Q1 | MNTR |
Operating Lease Liabilities Current
OperatingLeaseLiabilitiesCurrent
|
64484 | usd |
CY2022Q4 | MNTR |
Operating Lease Liabilities Current
OperatingLeaseLiabilitiesCurrent
|
62861 | usd |
CY2023Q1 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
290480 | usd |
CY2022Q4 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
307303 | usd |
CY2023Q1 | us-gaap |
Finance Lease Liability Payments Remainder Of Fiscal Year
FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear
|
225738 | usd |
CY2023Q1 | us-gaap |
Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
|
64484 | usd |
CY2023Q1 | us-gaap |
Finance Lease Liability Payments Due Next Twelve Months
FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
|
306365 | usd |
CY2023Q1 | us-gaap |
Lessee Operating Lease Liability Payments Due Next Rolling Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths
|
71279 | usd |
CY2023Q1 | us-gaap |
Finance Lease Liability Payments Due In Rolling Year Two
FinanceLeaseLiabilityPaymentsDueInRollingYearTwo
|
290463 | usd |
CY2023Q1 | us-gaap |
Lessee Operating Lease Liability Payments Due In Rolling Year Two
LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo
|
78611 | usd |
CY2023Q1 | us-gaap |
Finance Lease Liability Payments Due In Rolling Year Three
FinanceLeaseLiabilityPaymentsDueInRollingYearThree
|
226040 | usd |
CY2023Q1 | us-gaap |
Lessee Operating Lease Liability Payments Due In Rolling Year Three
LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree
|
86511 | usd |
CY2023Q1 | us-gaap |
Finance Lease Liability Payments Due In Rolling Year Four
FinanceLeaseLiabilityPaymentsDueInRollingYearFour
|
72127 | usd |
CY2023Q1 | us-gaap |
Lessee Operating Lease Liability Payments Due In Rolling Year Four
LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour
|
54077 | usd |
CY2023Q1 | us-gaap |
Finance Lease Liability
FinanceLeaseLiability
|
1120733 | usd |
CY2023Q1 | us-gaap |
Operating Lease Liability
OperatingLeaseLiability
|
354964 | usd |
CY2023Q1 | us-gaap |
Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
|
225738 | usd |
CY2023Q1 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
64484 | usd |
CY2023Q1 | us-gaap |
Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
|
894995 | usd |
CY2023Q1 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
290480 | usd |
CY2022Q4 | us-gaap |
Sales Type And Direct Financing Leases Lease Receivable
SalesTypeAndDirectFinancingLeasesLeaseReceivable
|
0 | usd |
CY2023Q1 | MNTR |
Long Term Debt One
LongTermDebtOne
|
17115 | usd |
CY2022Q4 | MNTR |
Long Term Debt One
LongTermDebtOne
|
18427 | usd |
CY2023Q1 | MNTR |
Long Term Debt Two
LongTermDebtTwo
|
40903 | usd |
CY2022Q4 | MNTR |
Long Term Debt Two
LongTermDebtTwo
|
44529 | usd |
CY2023Q1 | us-gaap |
Warrants And Rights Outstanding Maturity Date
WarrantsAndRightsOutstandingMaturityDate
|
1998-08-21 | |
CY2023Q1 | MNTR |
Warrant Redemption Price
WarrantRedemptionPrice
|
0.10 | |
CY2023Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms
|
P15Y3M18D | |
CY2022 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms
|
P15Y6M | |
CY2023Q1 | us-gaap |
Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
|
2.11 | |
CY2022Q4 | us-gaap |
Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
|
2.11 | |
CY2023Q1 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding
SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding
|
0 | usd |
CY2022Q4 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding
SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding
|
0 | usd |
CY2023Q1 | MNTR |
Warrant Redemption Price
WarrantRedemptionPrice
|
0.10 | |
CY2022Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
75000000 | shares |
CY2023Q1 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
75000000 | shares |
CY2023Q1 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
CY2022Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
CY2014Q3 | us-gaap |
Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
|
300000 | shares |
CY2023Q1 | us-gaap |
Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
|
44748 | shares |
CY2022 | us-gaap |
Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
|
44748 | shares |
CY2023Q1 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
5000000 | shares |
CY2022Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
5000000 | shares |
CY2023Q1 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.0001 | |
CY2022Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.0001 | |
CY2023Q1 | MNTR |
Long Term Debt Three
LongTermDebtThree
|
19059 | usd |
CY2022Q4 | MNTR |
Long Term Debt Three
LongTermDebtThree
|
20920 | usd |
CY2023Q1 | us-gaap |
Long Term Notes Payable
LongTermNotesPayable
|
77077 | usd |
CY2022Q4 | us-gaap |
Long Term Notes Payable
LongTermNotesPayable
|
83876 | usd |
CY2023Q1 | us-gaap |
Long Term Debt Current
LongTermDebtCurrent
|
30266 | usd |
CY2022Q4 | us-gaap |
Long Term Debt Current
LongTermDebtCurrent
|
29011 | usd |
CY2023Q1 | us-gaap |
Long Term Debt Noncurrent
LongTermDebtNoncurrent
|
46811 | usd |
CY2022Q4 | us-gaap |
Long Term Debt Noncurrent
LongTermDebtNoncurrent
|
54865 | usd |
CY2023Q1 | MNTR |
Accrued Salaries And Benefits
AccruedSalariesAndBenefits
|
922276 | usd |
CY2022Q4 | MNTR |
Accrued Salaries And Benefits
AccruedSalariesAndBenefits
|
914072 | usd |
CY2023Q1 | MNTR |
Accrued Retirement And Other Benefits
AccruedRetirementAndOtherBenefits
|
499823 | usd |
CY2022Q4 | MNTR |
Accrued Retirement And Other Benefits
AccruedRetirementAndOtherBenefits
|
501529 | usd |
CY2023Q1 | MNTR |
Offset By Shareholder Advance
OffsetByShareholderAdvance
|
-261653 | usd |
CY2022Q4 | MNTR |
Offset By Shareholder Advance
OffsetByShareholderAdvance
|
-261653 | usd |
CY2023Q1 | us-gaap |
Defined Benefit Pension Plan Liabilities Noncurrent
DefinedBenefitPensionPlanLiabilitiesNoncurrent
|
1160446 | usd |
CY2022Q4 | us-gaap |
Defined Benefit Pension Plan Liabilities Noncurrent
DefinedBenefitPensionPlanLiabilitiesNoncurrent
|
1153948 | usd |
CY2023Q1 | MNTR |
Incentive Fee Percentage
IncentiveFeePercentage
|
0.01 | pure |
CY2023Q1 | us-gaap |
Capitalization Longterm Debt And Equity
CapitalizationLongtermDebtAndEquity
|
260000 | usd |
CY2023Q1 | MNTR |
Market Capitalization Rate
MarketCapitalizationRate
|
0.005 | pure |
CY2023Q1 | us-gaap |
Stock Option Exercise Price Increase
StockOptionExercisePriceIncrease
|
1 | |
CY2023Q1 | us-gaap |
Incentive Fee Expense
IncentiveFeeExpense
|
0 | usd |
CY2022Q1 | us-gaap |
Incentive Fee Expense
IncentiveFeeExpense
|
0 | usd |
CY2023Q1 | us-gaap |
Loss Contingency Lawsuit Filing Date
LossContingencyLawsuitFilingDate
|
May 28, 2019 | |
CY2023Q1 | us-gaap |
Number Of Reportable Segments
NumberOfReportableSegments
|
2 | segment |
CY2023Q1 | us-gaap |
Revenues
Revenues
|
2175135 | usd |
CY2023Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
72614 | usd |
CY2023Q1 | us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
6660 | usd |
CY2023Q1 | us-gaap |
Interest Expense
InterestExpense
|
18959 | usd |
CY2023Q1 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
14446 | usd |
CY2023Q1 | us-gaap |
Assets
Assets
|
5232093 | usd |
CY2022Q1 | us-gaap |
Revenues
Revenues
|
1848898 | usd |
CY2022Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
31376 | usd |
CY2022Q1 | us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
14353 | usd |
CY2022Q1 | us-gaap |
Interest Expense
InterestExpense
|
18207 | usd |
CY2022Q1 | MNTR |
Property Additions
PropertyAdditions
|
27902 | usd |
CY2022Q1 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
15890 | usd |
CY2022Q1 | us-gaap |
Assets
Assets
|
4836918 | usd |
CY2023Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
72614 | usd |
CY2022Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
31376 | usd |
CY2022Q1 | us-gaap |
Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
|
-42680 | usd |
CY2023Q1 | us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
6660 | usd |
CY2022Q1 | us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
14353 | usd |
CY2023Q1 | us-gaap |
Interest Expense
InterestExpense
|
18959 | usd |
CY2022Q1 | us-gaap |
Interest Expense
InterestExpense
|
18207 | usd |
CY2022Q1 | us-gaap |
Gain Loss On Sale Of Property
GainLossOnSaleOfProperty
|
26168 | usd |
CY2023Q1 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
12118 | usd |
CY2022Q1 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
1500 | usd |
CY2023Q1 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
72433 | usd |
CY2022Q1 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
12510 | usd |